![Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma - ScienceDirect Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610820301641-fx1.jpg)
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma - ScienceDirect
![PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis | Cancer Gene Therapy PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis | Cancer Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41417-019-0109-7/MediaObjects/41417_2019_109_Fig1_HTML.png)
PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis | Cancer Gene Therapy
![Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes | Epigenomics Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes | Epigenomics](https://www.futuremedicine.com/cms/10.2217/epi-2018-0057/asset/images/medium/figure2.gif)
Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes | Epigenomics
![Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types. - Abstract - Europe PMC Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7031496/bin/fimmu-11-00057-g0002.jpg)
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types. - Abstract - Europe PMC
![Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report | EMBO Molecular Medicine Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/f9d2621a-9dee-444c-8c50-c676ec3b78ef/emmm201911756-fig-0002-m.jpg)
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report | EMBO Molecular Medicine
![A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery | Science Advances A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf0197/asset/36982973-20c6-4048-8212-0935937da585/assets/graphic/abf0197-f1.jpeg)
A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery | Science Advances
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
![Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation | Cell Death & Disease Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-021-04126-4/MediaObjects/41419_2021_4126_Fig1_HTML.png)
Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation | Cell Death & Disease
![High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma [PeerJ] High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11697/1/fig-1-full.png)
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma [PeerJ]
![Identification of aberrantly methylated‑differentially expressed genes and gene ontology in prostate cancer Identification of aberrantly methylated‑differentially expressed genes and gene ontology in prostate cancer](https://www.spandidos-publications.com/article_images/mmr/21/2/MMR-21-02-0744-g06.jpg)